An De Creus

1.1k total citations
25 papers, 869 citations indexed

About

An De Creus is a scholar working on Immunology, Epidemiology and Oncology. According to data from OpenAlex, An De Creus has authored 25 papers receiving a total of 869 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 7 papers in Epidemiology and 6 papers in Oncology. Recurrent topics in An De Creus's work include Immune Cell Function and Interaction (13 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (8 papers). An De Creus is often cited by papers focused on Immune Cell Function and Interaction (13 papers), Immunotherapy and Immune Responses (10 papers) and T-cell and B-cell Immunology (8 papers). An De Creus collaborates with scholars based in Belgium, United States and New Zealand. An De Creus's co-authors include Angus W. Thomson, Masanori Abe, Zhiliang Wang, Giorgio Raimondi, Katrien Van Beneden, Georges Leclercq, Veronique Debacker, Jean Plum, Yuk Yuen Lan and Bridget L. Colvin and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and Journal of Hepatology.

In The Last Decade

An De Creus

24 papers receiving 851 citations

Peers

An De Creus
Des C. Jones United Kingdom
Tomas Castro‐Dopico United Kingdom
James T. Snyder United States
Kazuhito Honjo United States
Yan Tang China
Petra Hoehn Germany
Alaap B. Shah United States
Kevin D. Cook United States
Des C. Jones United Kingdom
An De Creus
Citations per year, relative to An De Creus An De Creus (= 1×) peers Des C. Jones

Countries citing papers authored by An De Creus

Since Specialization
Citations

This map shows the geographic impact of An De Creus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An De Creus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An De Creus more than expected).

Fields of papers citing papers by An De Creus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An De Creus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An De Creus. The network helps show where An De Creus may publish in the future.

Co-authorship network of co-authors of An De Creus

This figure shows the co-authorship network connecting the top 25 collaborators of An De Creus. A scholar is included among the top collaborators of An De Creus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with An De Creus. An De Creus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pierson, Wim, Marianne Tuefferd, Florence Herschke, et al.. (2023). A single, oral dose of the TLR7 agonist JNJ-64794964 induces transcriptomic and phenotypic changes in peripheral immune cells in healthy adults. Antiviral Therapy. 28(3). 211898638–211898638.
3.
Hu, Yue, Edward Gane, Leen Slaets, et al.. (2023). Population pharmacokinetic/pharmacodynamic models of JNJ-64794964, a toll-like receptor 7 agonist, in healthy adult participants. Antiviral Therapy. 28(1). 211877386–211877386. 2 indexed citations
4.
Gehring, Adam J., Patricia Méndez, Kirsten Richter, et al.. (2022). Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection. Journal of Hepatology. 77(2). 525–538. 27 indexed citations
5.
Creus, An De, Leen Slaets, Bart Fevery, et al.. (2022). Therapeutic vaccine JNJ-0535 induces a strong HBV-specific T-cell response in healthy adults and a modest response in chronic HBV-infected patients. Journal of Hepatology. 77. S72–S73. 6 indexed citations
6.
Herschke, Florence, Chris Li, Ren Zhu, et al.. (2021). JNJ-64794964 (AL-034/TQ-A3334), a TLR7 agonist, induces sustained anti-HBV activity in AAV/HBV mice via non-cytolytic mechanisms. Antiviral Research. 196. 105196–105196. 10 indexed citations
8.
Pan, Szu‐Hua, Kang‐Yi Su, Bart Spiessens, et al.. (2016). Gene expression of MAGE‐A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients. Asia-Pacific Journal of Clinical Oncology. 13(5). e212–e223. 19 indexed citations
9.
Remaut, E., et al.. (2008). Genetically Engineered Lactococcus lactis Secreting Murine IL‐10 Modulates the Functions of Bone Marrow‐Derived Dendritic Cells in the Presence of LPS. Scandinavian Journal of Immunology. 69(2). 130–139. 7 indexed citations
10.
Creus, An De, et al.. (2007). Murine Trefoil Factor 3 Does not Directly Modulate LPS‐Mediated Dendritic Cell Function. Scandinavian Journal of Immunology. 66(1). 35–42. 3 indexed citations
11.
Huibregtse, Inge L., Veerle Snoeck, An De Creus, et al.. (2007). Induction of Ovalbumin-Specific Tolerance by Oral Administration of Lactococcus lactis Secreting Ovalbumin. Gastroenterology. 133(2). 517–528. 84 indexed citations
12.
Lan, Yuk Yuen, Zhiliang Wang, Giorgio Raimondi, et al.. (2006). “Alternatively Activated” Dendritic Cells Preferentially Secrete IL-10, Expand Foxp3+CD4+ T Cells, and Induce Long-Term Organ Allograft Survival in Combination with CTLA4-Ig. The Journal of Immunology. 177(9). 5868–5877. 129 indexed citations
13.
Creus, An De, Masanori Abe, Audrey Lau, et al.. (2005). Low TLR4 Expression by Liver Dendritic Cells Correlates with Reduced Capacity to Activate Allogeneic T Cells in Response to Endotoxin. The Journal of Immunology. 174(4). 2037–2045. 122 indexed citations
14.
Abe, Masanori, Zhiliang Wang, An De Creus, & Angus W. Thomson. (2005). Plasmacytoid Dendritic Cell Precursors Induce Allogeneic T‐Cell Hyporesponsiveness and Prolong Heart Graft Survival. American Journal of Transplantation. 5(8). 1808–1819. 103 indexed citations
15.
Lan, Yuk Yuen, An De Creus, Bridget L. Colvin, et al.. (2005). The Sphingosine‐1‐Phosphate Receptor Agonist FTY720 Modulates Dendritic Cell Trafficking In Vivo. American Journal of Transplantation. 5(11). 2649–2659. 97 indexed citations
16.
Wang, Zhiliang, A. Castellaneta, An De Creus, et al.. (2004). Heart, but Not Skin, Allografts from Donors Lacking Flt3 Ligand Exhibit Markedly Prolonged Survival Time. The Journal of Immunology. 172(10). 5924–5930. 15 indexed citations
17.
Beneden, Katrien Van, An De Creus, Frederik Stevenaert, et al.. (2002). Expression of Inhibitory Receptors Ly49E and CD94/NKG2 on Fetal Thymic and Adult Epidermal TCR Vγ3 Lymphocytes. The Journal of Immunology. 168(7). 3295–3302. 48 indexed citations
18.
Creus, An De, Katrien Van Beneden, Frederik Stevenaert, et al.. (2002). Developmental and Functional Defects of Thymic and Epidermal Vγ3 Cells in IL-15-Deficient and IFN Regulatory Factor-1-Deficient Mice. The Journal of Immunology. 168(12). 6486–6493. 75 indexed citations
19.
Beneden, Katrien Van, Frederik Stevenaert, An De Creus, et al.. (2001). Expression of Ly49E and CD94/NKG2 on Fetal and Adult NK Cells. The Journal of Immunology. 166(7). 4302–4311. 52 indexed citations
20.
Creus, An De, Katrien Van Beneden, Tom Taghon, et al.. (2000). Langerhans Cells That Have Matured In Vivo in the Absence of T Cells Are Fully Capable of Inducing a Helper CD4 as Well as a Cytotoxic CD8 Response. The Journal of Immunology. 165(2). 645–653. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026